Accessibility: Skip TopNav
Photo 1
Percent change in Target Lesion from Screening to Cycle 3B Day 1 with Overall response (Efficacy population)
Format
PNG
Source
Noxopharm, Ltd.
Downloads
Original
Large
Medium
Small